Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening Products

Nicotine-Induced Sudden Infant Death Syndrome May Be Prevented By Simple Drug Treatment
A new study has identified a specific class of pharmaceutical drugs that could be effective in treating babies vulnerable to Sudden Infant Death Syndrome (SIDS), because their mothers smoked during pregnancy.
generic viagra online
Small Business: The Hunt For Affordable Health Insurance
"For entrepreneurs trying to start or run a business, the obstacles are huge. But few loom as large as one: health care," the Wall Street Journal reports. "At some businesses, in fact, health care is the highest expense after salaries - with devastating consequences. Owners must skimp on vital investments like marketing and research. Some can"t hire the people they want because top candidates demand premium coverage. Or they end up understaffed because of the high cost of insurance - and lose potential clients as a result. At the same time, to keep costs in check, countless companies are slashing coverage or dropping it entirely. Some are turning to freelancers or offshore workers instead of hiring full-timers and locals. And some would-be entrepreneurs find insurance so onerous that they"re not even starting a business in the first place."
News of the day
What Is Scurvy? What Causes Scurvy?
Scurvy is a condition where an individual has a vitamin C (ascorbic acid) deficiency. The name scurvy comes from the Latin scorbutus, and humans have known about the disease since ancient Greek and Egyptian times. Scurvy commonly is associated with sailors in the 16th to 18th centuries who navigated long voyages without enough vitamin C and frequently perished from the condition. Modern cases of scurvy are very rare.
Cardiovascular

New York Times Examines Pilot Program To Fight Drug-Resistant TB In South African Communities

The New York Times examines a Doctors Without Borders pilot program to fight drug-resistant tuberculosis in South Africa that allows patients to stay in their homes rather than be isolated in hospital during treatment. The program, which is supported by the city of Cape Town and the Western Cape Province, aims to "show that such patients can be successfully treated in an impoverished community ò€¦ even while they are still infectious," the New York Times writes. Cheryl McDermid, a Canadian doctor with Doctors Without Borders, manages the program in the town of Khayelitsha. "About a fifth of the patients enrolled last year died, either while waiting weeks for a diagnosis or after treatment began. One in six of those who started treatment dropped out. But most patients have stuck with it and are now no longer infectious," the newspaper writes. McDermid said although it is still too early to know what the treatment success rate will be, there is no evidence that patients in the program are infecting the people who live with them. "Drug-resistant tuberculosis is a mounting global health threat," according to the newspaper. The disease is a "particularly virulent problem in Africa, where AIDS has heightened the vulnerability of millions," the New York Times writes. According to Paul Nunn, coordinator of the drug-resistance unit in the WHO"s TB department, ten African countries do not even have laboratories that can detect drug-resistant TB (Dugger, 7/28). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009